📌 Key Takeaways
- A June 2026 peer-reviewed study in Dermatologic Surgery (Vol.52, No.6)
evaluated 74 papers and scientifically redefined regenerative aesthetics
into three distinct pillars. - PRP and exosomes belong to the “biochemical cues” category —
not the same as scaffolds like Sculptra or RADIESSE,
which work through an entirely different mechanism. - Nanofat (mechanically emulsified adipose tissue) was highlighted as a
2026 emerging technology with potentially higher SVF yield
and fewer regulatory hurdles than enzymatic processing. - The study critically notes that “regeneration,” “repair,” “remodeling,”
and “biostimulation” are distinct mechanisms —
and that conflating them is a root cause of patient expectation mismatches.
“I had PRP injected.”
“I received an exosome IV drip.”
“Sculptra increased my collagen.” —
Many clinics market all three under the umbrella of “regenerative aesthetics.”
But a peer-reviewed study published in Dermatologic Surgery in June 2026
draws a clear scientific line: these treatments operate through fundamentally different mechanisms
and must be distinguished accordingly.
INDEX
The Three Pillars of Regenerative Aesthetics
Regeneration, Repair, Remodeling, Biostimulation — Four Terms That Are Not Interchangeable
Regeneration: The complete restoration of lost tissue or cells
to their original structure and function.
Example: A wound healing with identical tissue (biologically ideal, rarely achieved).
Repair: Filling damage with scar tissue.
Partial function is restored, but the original structure is not.
Example: A surgical incision closing with a scar.
Remodeling: Reorganizing and improving the structure of existing tissue.
Example: Collagen fiber alignment improving,
resulting in increased skin elasticity.
Biostimulation: Using external stimuli to enhance cellular production activity.
Example: Sculptra stimulating fibroblasts to produce collagen.
Most treatments marketed as “regenerative aesthetics” in clinics
are more accurately classified as biostimulation or remodeling.
This is not a lesser category —
it simply deserves to be described with precision.
The Real-World Consequences of Misusing the Word “Regeneration”
Issue ①: Expectation Mismatch
A patient who consents to treatment described as “regenerative medicine”
may later discover they received a collagen-induction injection.
The gap between expectation (complete tissue rejuvenation)
and reality (increased collagen production)
is a documented source of patient dissatisfaction and disputes.
Issue ②: Regulatory and Advertising Compliance Risk
Claims such as “complete tissue rejuvenation through regenerative medicine”
may constitute misleading advertising under medical advertising guidelines
in multiple jurisdictions.
Japan’s Ministry of Health, Labour and Welfare explicitly prohibits
promotional claims that exaggerate efficacy without scientific basis.
Issue ③: Regulatory Classification Becomes Opaque
When cellular therapies (which require regulatory notification under Japan’s Act on the Safety of Regenerative Medicine)
and exosomes or PRP (which fall under different or no such requirements)
are all labeled “regenerative aesthetics,”
patients lose the ability to determine whether a treatment is regulated.
Patients have the right to ask:
“Has this clinic filed the required notification for regenerative medicine?”
request documentation of cell type and quality certification;
ask about protocols for managing adverse events.
ask the provider to explain what the signaling molecules target
and through what mechanism.
the degradation and absorption timeline,
and the expected onset and duration of results.
Even among the clinics NERO has covered,
the use of the term “regenerative medicine” varies enormously.
From a consumer protection standpoint,
this word demands a clear, enforceable definition.
The fact that this peer-reviewed study has received almost no coverage
in Japanese-language media reflects a familiar pattern:
papers that organize inconvenient truths rarely go viral.
That is precisely the role NERO exists to fill.
Asking “Is this truly regeneration, or merely stimulation?”
is not skepticism — it is a patient’s right.
The precision of language determines the quality of medicine.
Summary
- A June 2026 peer-reviewed study in Dermatologic Surgery evaluated 74 papers
and scientifically organized regenerative aesthetics into
three pillars: cellular treatments, biochemical cues, and scaffolds. - PRP and exosomes are classified as “biochemical cues”;
Sculptra and RADIESSE are classified as “scaffolds.”
Describing all of them as “collagen-boosting injections” is inaccurate —
their mechanisms are fundamentally different. - “Regeneration,” “repair,” “remodeling,” and “biostimulation”
are distinct mechanisms.
Most treatments marketed as regenerative aesthetics
are more precisely biostimulation or remodeling. - Patients have the right to ask their provider:
“What is this treatment doing, through what mechanism,
to what degree, and for how long?”
Frequently Asked Questions
PRP delivers growth factors derived from your own blood.
Exosomes deliver intercellular signaling molecules.
Neither is inherently superior —
the appropriate choice depends on the treatment goal,
target area, and individual patient profile.
Ask your provider to explain the specific rationale
for recommending one over the other.
Sculptra (PLLA) works by forming a scaffold that stimulates fibroblasts
to produce collagen — a process classified as biostimulation, not regeneration.
It does not fall under Japan’s Act on the Safety of Regenerative Medicine.
If you want to confirm whether a treatment at a specific clinic
has been filed under that Act, contact the clinic directly.
any medical institution providing cell-based regenerative therapies
is required to file a notification with the Ministry of Health, Labour and Welfare.
Patients can verify compliance by searching the official MHLW registry
of approved regenerative medicine providers.
Receiving a cell-based treatment at an unregistered facility
carries significant patient safety risks.
Sources: Drago L et al. “Regenerative Aesthetics: Present Advances and Emerging Therapies” Dermatologic Surgery 52(6):548-560, June 2026 (DOI: 10.1097/DSS.0000000000004985) / Merenda V et al. “What regenerative means in aesthetic medicine: a narrative literature review” Plast Aesthet Res. 2026;13:5 (DOI: 10.20517/2347-9264.2025.127) / PMC “Regeneration in Aesthetic Medicine: Mechanisms, Evidence, and Clinical Boundaries” Journal of Cosmetic Dermatology 2026 (Wiley, DOI: 10.1111/jocd.70788) / AEDITION “The New Regenerative Aesthetic Treatments You Need to Know for 2026” December 30, 2025
